.png){kind=icon}
Return
Mutant p53: evolving perspectives
.png){kind=icon}
PRE
AI
DOI：10.1101/gad.353408.125.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The discovery of the p53 tumor suppressor protein raised fundamental questions about cell cycle regulation that have spanned several decades. TP53 mutations are found in most human cancers, most frequently as missense alterations in the DNA-binding domain (DBD). As a master regulator of both cell-intrinsic and cell-extrinsic functions, mutant p53 contributes to pro-oncogenic activities through gain-of-function (GOF) properties in addition to loss-of-function (LOF) and dominant-negative effects (DNEs). New technologies and improved fidelity of model systems are uncovering the functional consequences caused by p53 mutations at the molecular, cellular, and tissue levels. In a new era of precision medicine, with the context of recent success in targeting genetic mutations, ongoing and future understanding of fundamental mutant p53 biology is of paramount importance.
Keywords:
p53 mutation
gain of function
loss of function
dominant-negative effect
Journal
G
IF:
7.7
Papers:
71
Citations:
0
Organization
Cited Papers
ShareSaveShareSaveComparative proteome analysis to explore p53 pathway disruption in head and neck carcinogenesis
PREAI
ShareSaveThe DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
OAAI
OAAIShareSaveLi-Fraumeni Syndrome-Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death.png)
CANCER DISCOVERY
OAAI
CANCER DISCOVERYIF33.3
OAAIShareSaveCancer-derived p53 mutants suppress p53-target gene expression - potential mechanism for gain of function of mutant p53NUCLEIC ACIDS RESEARCHOAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAIShareSaveC-BERST: defining subnuclear proteomic landscapes at genomic elements with dCas9-APEX2NATURE METHODSOAAI
NATURE METHODSIF32.1
OAAIShareSaveShareSaveLocalization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: Mutant p53 activities are distinct from wild-typeCANCER LETTERS
CANCER LETTERSIF10.1
PREAI
ShareSave
View more